Syon Capital LLC Novo Cure LTD Transaction History
Syon Capital LLC
- $1.86 Trillion
- Q3 2025
A detailed history of Syon Capital LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Syon Capital LLC holds 13,663 shares of NVCR stock, worth $154,665. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,663
Previous 17,457
21.73%
Holding current value
$154,665
Previous $311 Million
43.19%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
290Shares Held
74.2MCall Options Held
1.26MPut Options Held
247K-
Black Rock Inc. New York, NY12.1MShares$137 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$118 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT9.64MShares$109 Million7.58% of portfolio
-
State Street Corp Boston, MA2.61MShares$29.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.47MShares$28 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.19B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...